IPO registrations (S-1, F-1) · Registrants

TAPESTRY PHARMACEUTICALS, INC

SEC CIK: 891504 · filings on EDGAR ↗
Former names: NAPRO BIOTHERAPEUTICS INC (1996–2004)
Registration: Form S-1, first filed 1996-06-03, last 2007-04-23; 2 initial registrations, 3 amendments
Outcome: Final prospectus filed 1997-12-31; withdrawal requested 2007-06-12
Industry (SIC): Medicinal Chemicals & Botanical Products 2833
Incorporated in: DE
Business address: 4840 PEARL EAST CIRCLE, SUITE 300W, Boulder, CO 80301
EIN: 84-1187753
EDGAR entity type: operating
Insiders and CEO pay: TAPESTRY PHARMACEUTICALS, INC on the corporate pages

Offering terms

Final price: $10.00 per share (424B4 filed 1997-12-31)
Shares sold: 1,000,000
Gross proceeds: $10,000,000 before underwriting discounts and any over-allotment option
Listing: Nasdaq under the symbol NPRO
Lead underwriters: J.P. Morgan (532,500 shares)
Syndicate: Vector Securities International, Inc (532,500); BT Securities Corporation (35,000); Credit Suisse (35,000); A.G. Edwards (35,000); Lehman Brothers (35,000); PaineWebber (35,000); Citigroup (35,000); UBS (35,000); Allen & Company (35,000); Cowen (15,000); Crowell, Weedon & Co (15,000); Cruttendon Roth Incorporated (15,000); Everen Securities, Inc (15,000); Genesis Merchant Group Securities (15,000); Gerard Klauer Mattison & Co., LLC (15,000); Hanifen, Imhoff Inc (15,000); Jefferies (15,000); Ladenburg Thalmann (15,000); Legg Mason (15,000); KeyBanc Capital Markets (15,000); Mesirow Financial, Inc (15,000); Nesbitt Burns Securities Inc (15,000); Rauscher Pierce Refsnes, Inc (15,000); Starr Securities, Inc (15,000); Sutro & Co. Incorporated (15,000); Van Kasper & Company (15,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

SEC filer: TAPESTRY PHARMACEUTICALS, INC EXACT (CIK (EXACT))

Filings 7

Filed	Form	What it is	Name as filed	EDGAR
1996-06-03	S-1	S-1 (registration)	NAPRO BIOTHERAPEUTICS INC	0000950130-96-002075 ↗
1996-07-01	S-1/A	S-1/A (amendment)	NAPRO BIOTHERAPEUTICS INC	0000950109-96-004205 ↗
1996-07-29	S-1/A	S-1/A (amendment)	NAPRO BIOTHERAPEUTICS INC	0000950109-96-004693 ↗
1996-08-01	S-1/A	S-1/A (amendment)	NAPRO BIOTHERAPEUTICS INC	0000950130-96-002813 ↗
1997-12-31	424B4	424B4 (final prospectus)	NAPRO BIOTHERAPEUTICS INC	0000927356-97-001501 ↗
2007-04-23	S-1	S-1 (registration)	TAPESTRY PHARMACEUTICALS, INC	0001047469-07-003101 ↗
2007-06-12	RW	RW (withdrawal request)	TAPESTRY PHARMACEUTICALS, INC	0001104659-07-047179 ↗

Prospectus pages read 2

Filed	Form	Read as	Range	Price	Shares	Proceeds	Listing	Underwriters	What was found	Document
1996-08-01	S-1/A	registration statement		$5.43	1,600,000	$8,688,000	Nasdaq NPRO	27	from the submission text; price line, shares headline, proceeds computed, underwriting table 27, cover names 1	document ↗
1997-12-31	424B4	final prospectus		$10.00	1,000,000	$10,000,000	Nasdaq NPRO	0	from the submission text; price line, shares headline, proceeds computed	document ↗

Officers, directors and large holders Forms 3, 4 and 5

Insider	Role	Title	Filings	Years
PILIA PATRICIA PH D	Director; Director,Officer	Executive VP	3	2006
BATT MARTIN	Officer	SVP, Chief Operating Officer	2	2006
CARTER STEPHEN K	Director		3	2006–2007
GOULD GEORGE M	Director		3	2006–2007
HAYES ARTHUR HULL JR	Director		2	2006–2007
LARSON KAI P	Officer	VP, General Counsel	2	2006
LINK GORDON H JR	Officer	CFO and Sr VP, Finance	2	2006
MAZA ELLIOTT M	Director		3	2006–2007
PERLE RICHARD N	Director		3	2006–2007
POLLACK ROBERT E	Director		3	2006–2007
SHAYKIN LEONARD P	Director,Officer	CEO	2	2006
TANG CAPITAL MANAGEMENT LLC	TenPercentOwner		4	2006–2008
TANG CAPITAL PARTNERS LP	TenPercentOwner		4	2006–2008
TANG KEVIN C	TenPercentOwner		4	2006–2008
MARXE AUSTIN W & GREENHOUSE DAVID M	TenPercentOwner		13	2006–2008
14159 capital (GP), LLC	TenPercentOwner		3	2006–2008
Baker Biotech Capital III (GP), LLC	TenPercentOwner		4	2006–2008
Baker Biotech Capital III (Z) (GP), LLC	TenPercentOwner		2	2006
Baker Biotech Capital II (Z) (GP), LLC	TenPercentOwner		2	2006
Baker Bros. Capital (GP), LLC	TenPercentOwner		4	2006–2008
BAKER FELIX	TenPercentOwner		13	2006–2008
BAKER JULIAN	TenPercentOwner		13	2006–2008
PICKER DONALD H	Officer	President	1	2007
Majoros Matthew J	Officer	Corporate Controller	1	2007
Cannon Martin A	Director		1	2007
Rowinsky Eric K	Director		1	2007
GOLDMAN SACHS & CO	TenPercentOwner		2	2008
GOLDMAN SACHS GROUP INC	TenPercentOwner		2	2008

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Record	Name as filed	Where	Dataset	Matched by
SEC filer	TAPESTRY PHARMACEUTICALS, INC		SEC filers (EDGAR)	CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Medicinal Chemicals & Botanical Products, CO first:

Pure Harvest Corporate Group, Inc. CO
DC BRANDS INTERNATIONAL INC CO
Phoenix Life Sciences International Limited. CO
PANACEA LIFE SCIENCES HOLDINGS, INC. CO
ANTARES CORP. CO
American Cannabis Company, Inc. CO
First Person Ltd. A0
CanaQuest Medical Corp. A6
Canopy Growth Corp A6
Devonian Health Group Inc. A8

More with this interest.

In other datasets, the same topic (Health) in CO:

Nonprofit: 3 4 FIGHTING PARKINSONS (Nonprofits (IRS Form 990))

Interests: Medicinal Chemicals & Botanical Products · Health